Douglas Research Insights

Douglas Research Insights

LivsMed IPO Book Building Results Analysis

Douglas Kim's avatar
Douglas Kim
Dec 12, 2025
∙ Paid
  • Livsmed confirmed its IPO price at 55,000 won, which is at the top end of the IPO price range. Demand ratio was 232 to 1.

  • A 98.8% of the IPO shares applied thought that the company’s value is 55,000 won or more.

  • Our base case valuation of Livsmed is implied market cap of 2.3 trillion won or target price of 88,294 won per share, representing a 61% upside from the IPO price.

User's avatar

Continue reading this post for free, courtesy of Douglas Kim.

Or purchase a paid subscription.
© 2026 Douglas Kim · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture